Table 3.
Disease | Gene product | Inheritance | Animal | Genetic modification | Reference |
---|---|---|---|---|---|
ALS2 | Alsin | Recessive | Mouse | KO (exon 3) | [50] |
KO (stop codon in exon 3) | [51] | ||||
KO (exon 3 and 4) | [52] | ||||
KO (exon 4) | [53] | ||||
ALS8 | VAPB | Dominant | Mouse | PrP; VAPB P56S | [54] |
ALS | Dynactin | Dominant | Mouse | Knock-in G59S p150Glued | [55] |
Thy-1; G59 p150Glued | [56, 57] | ||||
CMT2E/1F | Neurofilament-L | Dominant | Mouse | NF-L L394P | [58] |
NA | Peripherin | NA | Mouse | overexpression | [59] |
NA | Vascular endothelial growth factor | NA | Mouse | VEGFδ/δ | [60] |
FTDP-tau | tau | Dominant | Mouse | 4R human tau | [61] |
R406W human tau | [62, 63] | ||||
P301L human tau | [64] | ||||
G272V, P301S human tau | [65] | ||||
V337M human tau | [66] | ||||
P301S human tau | [67] |
PrP: prion promoter, CMT: Charcot-Marie-Tooth, FTDP: frontotemporal dementia with parkinsonism, and NA: not available.